Florida Senate - 2016 SB 938 By Senator Benacquisto 30-00935-16 2016938__ 1 A bill to be entitled 2 An act relating to the retail sale of 3 dextromethorphan; providing definitions; prohibiting a 4 retail entity from knowingly or willfully selling a 5 finished drug product containing dextromethorphan to a 6 person younger than 18 years of age; prohibiting a 7 person younger than 18 years of age from purchasing a 8 finished drug product containing dextromethorphan; 9 requiring a person making a retail sale of a finished 10 drug product containing any quantity of 11 dextromethorphan to obtain certain proof of age from 12 the purchaser; providing an exception; providing 13 penalties; providing applicability; preempting local 14 government regulation of dextromethorphan; providing 15 an effective date. 16 17 Be It Enacted by the Legislature of the State of Florida: 18 19 Section 1. Restrictions on sale of dextromethorphan.— 20 (1) As used in this section, the term: 21 (a) “Finished drug product” means a drug legally marketed 22 under the Federal Food, Drug, and Cosmetic Act that is in 23 finished dosage form. 24 (b) “Proof of age” means any document issued by a 25 governmental agency that contains the date of birth and a 26 description or photograph of the person purchasing the finished 27 drug product. The term includes, but is not limited to, a 28 passport, military identification card, or driver license. 29 (2)(a) A retail entity may not knowingly or willfully sell 30 a finished drug product containing any quantity of 31 dextromethorphan to a person younger than 18 years of age. 32 (b) A person younger than 18 years of age may not purchase 33 a finished drug product containing any quantity of 34 dextromethorphan. 35 (3) A person making a retail sale of a finished drug 36 product containing any quantity of dextromethorphan must require 37 and obtain proof of age from the purchaser before completing the 38 sale, unless from the purchaser’s outward appearance the person 39 making the sale would reasonably presume the purchaser to be 25 40 years of age or older. 41 (4)(a) A manufacturer, distributor, or retailer whose 42 employee or representative, during the course of the employee’s 43 or representative’s employment or association with the 44 manufacturer, distributor, or retailer, sells dextromethorphan 45 in violation of this section is subject to a $100 fine, except 46 that a manufacturer, distributor, or retailer who demonstrates a 47 good faith effort to comply with this section is not subject to 48 such penalty. 49 (b) An employee or representative of a manufacturer, 50 distributor, or retailer who, during the course of the 51 employee’s or representative’s employment or association with 52 the manufacturer, distributor, or retailer, sells 53 dextromethorphan in violation of this section is subject to a 54 $25 fine. 55 (c) A person who purchases dextromethorphan in violation of 56 this section is subject to a $25 fine. 57 (d) A person who possesses or receives dextromethorphan in 58 violation of this section, with the intent to distribute, is 59 subject to a $25 fine. 60 (5) This section does not: 61 (a) Impose any restriction on the placement of products in 62 a retail store, direct access of customers to finished drug 63 products, or the maintenance of transaction records. 64 (b) Apply to a medication containing dextromethorphan that 65 is sold by a retail entity pursuant to a valid prescription. 66 (6) This section preempts any ordinance regulating the 67 sale, distribution, receipt, or possession of dextromethorphan 68 enacted by a county, municipality, or other political 69 subdivision of the state, and dextromethorphan is not subject to 70 further regulation by such political subdivisions. 71 Section 2. This act shall take effect January 1, 2017.